The Contagion® HCV / Hepatitis specialty page provides HCV / hepatitis-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
The World Health Organization just published the first ever Global Hepatitis Report, which notes that the viral hepatitis mortality rate is increasing worldwide, while deaths caused by HIV and tuberculosis continues to drop.
Researchers from the Center for Disease Analysis investigated the incidence of hepatitis C in the European Union (EU) and examined the measures that would be needed to achieve the World Health Organization’s ultimate goal of eradicating the disease by 2030.
Doctors Without Borders and humanitarian groups across Europe are coordinating their opposition to Gilead Sciences Inc’s patent for hepatitis C treatment sofosbuvir, the basis for the biopharmaceutical giant’s Sovaldi, Harvoni, and Epclusa drugs.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512